Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Former Star-Ledger pharmaceuticals reporter Ed Silverman is considering reviving his blog, Pharmalot. He is now the legal owner of "Pharmalot.com" and is keeping the brand alive in the form of a ...

On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the ...

Pfizer will sell a biosimilar version of the Remicade rheumatoid arthritis treatment next month at a 15 percent discount off the list price of the brand-name drug.

FLICKR, VELKR0 Ed Silverman’s Pharmalot blog is back, with a new home at The Wall Street Journal.Earlier this year (January 2), the blog was shut down by its former parent company, UBM Canon, which ...

Drug makers spent $5.6 billion direct-to-consumer ads last year, a 9 percent increase, with Pfizer and Bristol-Myers Squibb leading the pack.

Once again, another working week will soon draw to a close and - along with it - the latest iteration of Pharmalot. Yes, you got that right. After a brief, but rewarding stay here at The Wall ...

Nonetheless, the Pharmalot campus is engulfed by a healthy amount of snow and still more is falling. This is a good time, then, to pick up a cup of stimulation and get busy foraging for ...

WIKIMEDIA, KEN HAWKINS Each day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the ...